These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 26636408)

  • 1. Nonalcoholic fatty liver is not associated with incident chronic kidney disease: a large histology-based comparison with healthy individuals.
    Choudhary NS; Saraf N; Kumar N; Rai R; Saigal S; Gautam D; Lipi L; Rastogi A; Goja S; Bhangui P; Ramchandra SK; Soin AS
    Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):441-3. PubMed ID: 26636408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of normal values of serum transaminases based on liver histology in healthy Asian Indians.
    Choudhary NS; Saraf N; Saigal S; Gautam D; Lipi L; Soin AS
    J Gastroenterol Hepatol; 2015 Apr; 30(4):763-6. PubMed ID: 25352365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of formulas for estimating glomerular filtration rate in Indigenous Australians with and without Type 2 diabetes: the eGFR Study.
    Maple-Brown LJ; Ekinci EI; Hughes JT; Chatfield M; Lawton PD; Jones GR; Ellis AG; Sinha A; Cass A; Hoy WE; O'Dea K; Jerums G; MacIsaac RJ;
    Diabet Med; 2014 Jul; 31(7):829-38. PubMed ID: 24598003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Portal inflammation predicts renal dysfunction in patients with nonalcoholic fatty liver disease.
    An JN; Joo SK; Koo BK; Kim JH; Oh S; Kim W
    Hepatol Int; 2020 Sep; 14(5):798-807. PubMed ID: 32557192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of nonalcoholic fatty liver in prospective liver donors.
    Choudhary NS; Saraf N; Saigal S; Duseja A; Gautam D; Lipi L; Rastogi A; Goja S; Bhangui P; Ramchandra SK; Babu YR; Soin AS
    Clin Transplant; 2017 Apr; 31(4):. PubMed ID: 27988988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management.
    McPherson S; Hardy T; Henderson E; Burt AD; Day CP; Anstee QM
    J Hepatol; 2015 May; 62(5):1148-55. PubMed ID: 25477264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and risk factors for non-alcoholic fatty liver in children and youth with obesity.
    Jimenez-Rivera C; Hadjiyannakis S; Davila J; Hurteau J; Aglipay M; Barrowman N; Adamo KB
    BMC Pediatr; 2017 Apr; 17(1):113. PubMed ID: 28446162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progression from Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis Is Marked by a Higher Frequency of Th17 Cells in the Liver and an Increased Th17/Resting Regulatory T Cell Ratio in Peripheral Blood and in the Liver.
    Rau M; Schilling AK; Meertens J; Hering I; Weiss J; Jurowich C; Kudlich T; Hermanns HM; Bantel H; Beyersdorf N; Geier A
    J Immunol; 2016 Jan; 196(1):97-105. PubMed ID: 26621860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver.
    Pais R; Charlotte F; Fedchuk L; Bedossa P; Lebray P; Poynard T; Ratziu V;
    J Hepatol; 2013 Sep; 59(3):550-6. PubMed ID: 23665288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of chronic kidney diseases in patients with chronic obstructive pulmonary disease: assessment based on glomerular filtration rate estimated from creatinine and cystatin C levels.
    Yoshizawa T; Okada K; Furuichi S; Ishiguro T; Yoshizawa A; Akahoshi T; Gon Y; Akashiba T; Hosokawa Y; Hashimoto S
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1283-9. PubMed ID: 26185434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uric acid levels correlate with baseline renal function and high levels are a potent risk factor for postoperative chronic kidney disease in patients with renal cell carcinoma.
    Jeon HG; Choo SH; Jeong BC; Seo SI; Jeon SS; Choi HY; Lee HM
    J Urol; 2013 Apr; 189(4):1249-54. PubMed ID: 23159461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimated Glomerular Filtration Rate Within the Normal or Mildly Impaired Range and Incident Cardiovascular Disease.
    Eisen A; Hoshen M; Balicer RD; Reges O; Rabi Y; Leibowitz M; Iakobishvili Z; Hasdai D
    Am J Med; 2015 Sep; 128(9):1015-22.e2. PubMed ID: 25863153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonalcoholic Fatty Liver in Lean Individuals: Clinicobiochemical Correlates of Histopathology in 157 Liver Biopsies from Healthy Liver Donors.
    Choudhary NS; Saraf N; Saigal S; Duseja A; Gautam D; Rastogi A; Bhangui P; Thiagrajan S; Soin AS
    J Clin Exp Hepatol; 2021; 11(5):544-549. PubMed ID: 34511814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement in liver histology due to lifestyle modification is independently associated with improved kidney function in patients with non-alcoholic steatohepatitis.
    Vilar-Gomez E; Calzadilla-Bertot L; Friedman SL; Gra-Oramas B; Gonzalez-Fabian L; Villa-Jimenez O; Lazo-Del Vallin S; Diago M; Adams LA; Romero-Gomez M; Chalasani N
    Aliment Pharmacol Ther; 2017 Jan; 45(2):332-344. PubMed ID: 27862096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired renal function in morbid obese patients with nonalcoholic fatty liver disease.
    Machado MV; Gonçalves S; Carepa F; Coutinho J; Costa A; Cortez-Pinto H
    Liver Int; 2012 Feb; 32(2):241-8. PubMed ID: 22098270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Comparison of Brunt's Criteria, the Non-Alcoholic Fatty Liver Disease Activity Score (NAS), and a Proposed NAS Scoring that Includes Fibrosis in Non-Alcoholic Fatty Liver Disease Staging.
    Santiago-Rolón A; Purcell D; Rosado K; Toro DH
    P R Health Sci J; 2015 Dec; 34(4):189-94. PubMed ID: 26602577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimal Improvement in Glomerular Filtration Rate in the First Year After Liver Transplantation.
    Mangus RS; Lutz AJ; Fridell JA; Kubal CA; Bush WJ; Tector AJ
    Transplantation; 2015 Sep; 99(9):1855-61. PubMed ID: 26308416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased prevalence of chronic kidney disease in patients with Type 1 diabetes and non-alcoholic fatty liver.
    Targher G; Pichiri I; Zoppini G; Trombetta M; Bonora E
    Diabet Med; 2012 Feb; 29(2):220-6. PubMed ID: 21883436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonalcoholic Fatty Liver: The Association with Metabolic Abnormalities, Body Mass Index and Central Obesity--A Population-Based Study.
    Ostovaneh MR; Zamani F; Ansari-Moghaddam A; Sharafkhah M; Saeedian FS; Rohani Z; Khoonsari M; Barzin G; Hemmasi G; Ajdarkosh H; Katoonizadeh A; Maadi M; Malekzadeh R; Poustchi H
    Metab Syndr Relat Disord; 2015 Sep; 13(7):304-11. PubMed ID: 26042518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of decreased estimated glomerular filtration rate using liver fibrosis markers: a renal biopsy-based study.
    Mima A
    Sci Rep; 2022 Oct; 12(1):17630. PubMed ID: 36271110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.